FDA Drug Recalls

Recalls / Class I

Class ID-1363-2020

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room temperature, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Affected lot / code info
Lot #: 01-09-2020:13@8, Exp. 7/7/2020

Why it was recalled

Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.

Recalling firm

Firm
MasterPharm LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
11502 Liberty Ave Fl 2, N/A, South Richmond Hill, New York 11419-1902

Distribution

Quantity
300 capsules
Distribution pattern
FL and MD

Timeline

Recall initiated
2020-06-09
FDA classified
2020-06-26
Posted by FDA
2020-07-08
Terminated
2023-10-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1363-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.